Clinical Trial Update: Functionalized Bioink Delivering Biomolecules for the Treatment of Craniofacial Diseases

View source ↗

Summary

Clinical trial update describes a functionalized bioink delivering biomolecules for craniofacial conditions, with the study currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Craniofacial Anomalies
• Craniosynostosis
• Skull Defects

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Craniofacial Defects, Subtle, Skull Defect | Status: ACTIVE_NOT_RECRUITING